[PDF] Top 20 Developments in the management and treatment of pulmonary embolism

... ABSTRACT Pulmonary embolism (PE) is a serious and costly disease for patients and healthcare systems. Guidelines emphasise the importance of differentiating between patients who are at high risk of ... See full document

... progression, treatment discontinuation, recurrence, or death) was significantly improved in the FOL- FIRI arm compared with epirubicin + cisplatin + capecit- abine (5 months vs 4 months, HR: ...noncisplatin-based ... See full document

... the pulmonary thromboemboli down to at least the segmental level but also RV enlarge- ment as an indicator of RV ...definitive treatment without further ...the pulmonary artery and its main branches, ... See full document

... The treatment should be continued in the case of MDR tuberculosis for at least 18 months after culture conversion to ensure stable therapy success, which is achieved in about 65% of ... See full document

... the treatment of schizophrenia because they improve positive and negative schizophrenic symptoms, however, in most cases after the remission of the acute psychotic symptoms, negative symptoms such as autism, ... See full document

... by pulmonary embolism in ...by pulmonary embolism (PE). We also reviewed all reports of pulmonary emboli resulting from MP infections in the past fifteen ...thrombolysis ... See full document

... outpatient management of pulmonary embolism ...empirical treatment with either low-molecular-weight heparin or apixaban or rivaroxaban and asked to return within 24 hours for definitive ... See full document

... acute pulmonary embolism remains a significant public health threat as the third most common cardiovascular cause of death, the current guidelines consider throm- bolysis the primary therapy despite its ... See full document

... 12. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep ... See full document

... PF-03654746 (NCT01006122) has been tested in a randomized, double-blind, placebo-controlled, crossover assignment, safety and efficacy study with starting dose of 0.25 mg titrated to a maximum of 2 mg to evaluate effects ... See full document

... successful treatment of rheumatoid arthritis (RA) with tumor necrosis factor alpha (TNF α ) blockade, the treatment of psoriasis and psoriatic arthritis (PsA) has been vastly improved in recent years with ... See full document

... appropriate treatment and setting of care. New ESC recommendations on PE management suggest that patients with low risk sPESI score should not receive further investigations such as right heart dysfunction ... See full document

... of pulmonary, cardiology, hematology, critical care, interventional radiology, or vascular surgery services depending on local availability and referral ...isolation treatment biases can become ... See full document

... nary embolism (PE). Currently, PE diagnosis and treatment are a challenge because of acute onset right ventricular strain with right-sided heart failure, sudden death, pulmonary infarction, and ... See full document

... of treatment in failed thrombolysis demonstrated that mortality in patients receiving repeat thrombolysis was 38% compared with 7% in patients undergoing embolectomy, although bias in management approach ... See full document

... TE management involve pulmonary lobectomy or pneumonectomy ...of treatment [24, 32]. When pulmonary embolectomy is not feasible or contraindi- cated, additional measures should be ... See full document

... Other reported side effects are mild and include: leg edema (in up to 3%), mild decreases in hemoglobin, and nasal congestion. Fluid retention, typically reported as increased lower extremity edema and/or weight gain, ... See full document

... Materials and methods: A prospective and parallel group study was performed on 64 cancer patients (29 males and 35 females) with APE. A multidetector CT angiography with high spatial and temporal resolution and quality ... See full document

... I pulmonary hypertension were elucidated, interest naturally shifted to its use in other types, namely in PH due to chronic throm- boembolic disease ...thE tReatment of Inoperable chronic Thromboembolic ... See full document

... targeted therapy represents the first step in a paradigm shift in the treatment of glioblastoma and cancer in general. Previ- ous therapies have been aimed at non-specifically inhibiting cell division or growth. ... See full document